BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

160 related articles for article (PubMed ID: 8388019)

  • 1. Complete nucleotide sequence of a coxsackie B5 virus and its relationship to swine vesicular disease virus.
    Zhang G; Wilsden G; Knowles NJ; McCauley JW
    J Gen Virol; 1993 May; 74 ( Pt 5)():845-53. PubMed ID: 8388019
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Differential diagnosis and genetic analysis of the antigenically related swine vesicular disease virus and coxsackie viruses.
    Marquardt O; Ohlinger VF
    J Virol Methods; 1995 Jun; 53(2-3):189-99. PubMed ID: 7673387
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The complete nucleotide sequence of swine vesicular disease virus.
    Inoue T; Suzuki T; Sekiguchi K
    J Gen Virol; 1989 Apr; 70 ( Pt 4)():919-34. PubMed ID: 2543767
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Comparison of swine vesicular disease virus and Coxsackie B5 virus by serological and RNA hybridization methods.
    Brown F; Wild TF; Rowe LW; Underwood BO; Harris TJ
    J Gen Virol; 1976 May; 31(2):231-7. PubMed ID: 58963
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Molecular evolution of swine vesicular disease virus.
    Zhang G; Haydon DT; Knowles NJ; McCauley JW
    J Gen Virol; 1999 Mar; 80 ( Pt 3)():639-651. PubMed ID: 10092004
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Echoviruses include genetically distinct serotypes.
    Auvinen P; Hyypiä T
    J Gen Virol; 1990 Sep; 71 ( Pt 9)():2133-9. PubMed ID: 2170575
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A comparative electrophoretic examination of swine vesicular disease virus and Coxsackie B5 virus.
    Sorensen KJ
    Arch Virol; 1977; 53(3):235-41. PubMed ID: 193464
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The complete nucleotide sequence of a pathogenic swine vesicular disease virus.
    Seechurn P; Knowles NJ; McCauley JW
    Virus Res; 1990 Jul; 16(3):255-74. PubMed ID: 2168111
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The nucleotide sequence of coxsackievirus A9; implications for receptor binding and enterovirus classification.
    Chang KH; Auvinen P; Hyypiä T; Stanway G
    J Gen Virol; 1989 Dec; 70 ( Pt 12)():3269-80. PubMed ID: 2558158
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Crystal structure of Swine vesicular disease virus and implications for host adaptation.
    Fry EE; Knowles NJ; Newman JW; Wilsden G; Rao Z; King AM; Stuart DI
    J Virol; 2003 May; 77(9):5475-86. PubMed ID: 12692248
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Genotypic variation in coxsackievirus B5 isolates from three different outbreaks in the United States.
    Kopecka H; Brown B; Pallansch M
    Virus Res; 1995 Oct; 38(2-3):125-36. PubMed ID: 8578854
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The genome of echovirus 11.
    Dahllund L; Nissinen L; Pulli T; Hyttinen VP; Stanway G; Hyypiä T
    Virus Res; 1995 Feb; 35(2):215-22. PubMed ID: 7762294
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The major echovirus group is genetically coherent and related to coxsackie B viruses.
    Huttunen P; Santti J; Pulli T; Hyypiä T
    J Gen Virol; 1996 Apr; 77 ( Pt 4)():715-25. PubMed ID: 8627260
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Molecular analysis of coxsackievirus A16 reveals a new genetic group of enteroviruses.
    Pöyry T; Hyypiä T; Horsnell C; Kinnunen L; Hovi T; Stanway G
    Virology; 1994 Aug; 202(2):982-7. PubMed ID: 8030260
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Intratypic genome variability of the coxsackievirus B1 2A protease region.
    Zoll J; Galama J; Melchers W
    J Gen Virol; 1994 Mar; 75 ( Pt 3)():687-92. PubMed ID: 8126468
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Characterization of neutralization sites on the circulating variant of swine vesicular disease virus (SVDV): a new site is shared by SVDV and the related coxsackie B5 virus.
    Borrego B; Carra E; García-Ranea JA; Brocchi E
    J Gen Virol; 2002 Jan; 83(Pt 1):35-44. PubMed ID: 11752698
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Coxsackievirus B5 and the relationship to swine vesicular disease virus.
    Knowles NJ; McCauley JW
    Curr Top Microbiol Immunol; 1997; 223():153-67. PubMed ID: 9294928
    [No Abstract]   [Full Text] [Related]  

  • 18. Characterization of three antigenic particles of swine vesicular disease virus.
    Moore DM
    J Gen Virol; 1977 Mar; 34(3):431-45. PubMed ID: 67181
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Comparison of proliferation and cytopathogenicity of swine vesicular virus and coxsackievirus B5.
    Lai SS; Breese SS; Moore DM; Gillespie JH
    Zhonghua Min Guo Wei Sheng Wu Ji Mian Yi Xue Za Zhi; 1981 Sep; 14(3):167-72. PubMed ID: 6269809
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The coxsackie-adenovirus receptor (CAR) is used by reference strains and clinical isolates representing all six serotypes of coxsackievirus group B and by swine vesicular disease virus.
    Martino TA; Petric M; Weingartl H; Bergelson JM; Opavsky MA; Richardson CD; Modlin JF; Finberg RW; Kain KC; Willis N; Gauntt CJ; Liu PP
    Virology; 2000 May; 271(1):99-108. PubMed ID: 10814575
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.